[{"anatomy": null, "operational taxonomic unit matrix": 38790, "16s ribosomal gene sequencing assay": 29987, "sequence trimming": 26627, "whole genome sequencing assay": 11491, "RNA-seq assay": 9271, "other": 63840}, {"anatomy": "large intestine", "L1000 mRNA profiling assay (provisional OBI term)": 23916, "Hi-C assay": 5100, "sequencing assay": 108, "ChIP-seq assay": 42}, {"anatomy": "breast", "L1000 mRNA profiling assay (provisional OBI term)": 23724, "microenvironment microarray assay (provisional OBI term)": 66, "fluorescence imaging based cell proliferation assay (provisional OBI term)": 47, "fluorescence imaging based cell viability assay (provisional OBI term)": 34, "microwestern meso-scale quantitative western blot assay (provisional OBI term)": 12, "other": 39}, {"anatomy": "blood", "whole genome sequencing assay": 20564, "exome sequencing assay": 825, "epigenetic modification assay": 228, "antigen specific antibodies assay": 210, "null": 131, "other": 162}, {"anatomy": "prostate gland", "L1000 mRNA profiling assay (provisional OBI term)": 14252, "microenvironment microarray assay (provisional OBI term)": 16, "fluorescence imaging based cell proliferation assay (provisional OBI term)": 11, "KiNativ assay (provisional OBI term)": 9, "Hi-C assay": 8, "other": 5}, {"anatomy": "kidney", "L1000 mRNA profiling assay (provisional OBI term)": 13255, "Hi-C assay": 424, "assay for transposase-accessible chromatin using sequencing": 36, "RNA sequencing assay": 34, "ChIP-seq assay": 24, "other": 25}, {"anatomy": "skin of body", "L1000 mRNA profiling assay (provisional OBI term)": 13134, "fluorescence imaging based cell proliferation assay (provisional OBI term)": 12, "KiNativ assay (provisional OBI term)": 8, "fluorescence imaging based protein phosphorylation state assay (provisional OBI term)": 6, "fluorescence imaging-based apoptosis assay (provisional OBI term)": 5, "other": 9}, {"anatomy": "skin of cheek", "whole genome sequencing assay": 11086, "null": 586}, {"anatomy": "feces", "16s ribosomal gene sequencing assay": 4949, "whole metagenome sequencing assay": 2833, "metabolite profiling assay": 2180, "RNA sequencing assay": 835, "protein expression profiling assay": 450, "other": 6}, {"anatomy": "pancreas", "L1000 mRNA profiling assay (provisional OBI term)": 11008, "fluorescence imaging based cell proliferation assay (provisional OBI term)": 12, "microenvironment microarray assay (provisional OBI term)": 12, "Hi-C assay": 8, "global chromatin epigenetic profiling assay (provisional OBI term)": 2, "other": 3}, {"anatomy": "blood plasma", "metabolite profiling assay": 6161, "protein expression profiling assay": 926, "RNA sequencing assay": 839, "cytokine assay": 369, "whole metagenome sequencing assay": 53, "other": 8}, {"anatomy": "tissue", "whole genome sequencing assay": 4273, "RNA-seq assay": 2879, "exome sequencing assay": 930, "null": 252}, {"anatomy": "other", "whole genome sequencing assay": 7595, "null": 130, "16s ribosomal gene sequencing assay": 20524, "cytokine assay": 1847, "whole metagenome sequencing assay": 4334, "RNA sequencing assay": 630, "lipid profiling assay": 69, "other": 11, "Hi-C assay": 10856, "L1000 mRNA profiling assay (provisional OBI term)": 17062, "fluorescence imaging based cell proliferation assay (provisional OBI term)": 269, "fluorescence imaging-based apoptosis assay (provisional OBI term)": 18, "P100 protein and phosphoprotein quantification assay (provisional OBI term)": 2, "global chromatin epigenetic profiling assay (provisional OBI term)": 2, "microscopy assay": 3878, "DNA sequencing assay": 36, "ChIP-seq assay": 234, "sequencing assay": 1320, "epigenetic modification assay": 220, "fluorescence imaging based cell cycle state assay (provisional OBI term)": 6, "assay for transposase-accessible chromatin using sequencing": 32, "fluorescence imaging multiplex cytological profiling (provisional OBI term)": 1, "RNA-seq assay": 164, "exome sequencing assay": 126, "KiNativ assay (provisional OBI term)": 11, "electron microscopy imaging assay": 8, "enzyme-linked immunosorbent assay": 2}]